HomeIRD • NASDAQ
add
Opus Genetics Inc
Previous close
$1.05
Day range
$1.01 - $1.05
Year range
$0.65 - $2.18
Market cap
62.35M USD
Avg Volume
1.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 4.37M | 155.41% |
Operating expense | 6.41M | 37.06% |
Net income | -8.19M | -15.31% |
Net profit margin | -187.51 | 54.85% |
Earnings per share | — | — |
EBITDA | -9.92M | -28.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.79M | -11.39% |
Total assets | 48.17M | -7.09% |
Total liabilities | 24.25M | 319.06% |
Total equity | 23.92M | — |
Shares outstanding | 59.66M | — |
Price to book | 9.55 | — |
Return on assets | -58.39% | — |
Return on capital | -100.33% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.19M | -15.31% |
Cash from operations | -8.99M | -57.35% |
Cash from investing | — | — |
Cash from financing | 20.46M | 761.32% |
Net change in cash | 11.47M | 443.44% |
Free cash flow | 6.97M | 309.12% |
About
Founded
2018
Headquarters
Website
Employees
18
